Clinical Trial Update: Identify the Benefits CAREGIVERSPRO-MMD Platform Use Based on the Information and Communications Technology, Dedicated to the Support and Assistance of Dyads Living With Neurocognitive Diseases and Their Primary Caregivers [NA]

View source ↗

Summary

The entry reports the completion of a clinical study evaluating the CAREGIVERSPRO-MMD ICT platform designed to support dyads living with neurocognitive diseases…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Dementia

Drugs mentioned

• CAREGIVERSPRO-MMD platform

Snippet

Sponsor: University Hospital, Rouen | Conditions: Cognitive Impairment, Mild, Dementia, Mild | NA | Status: COMPLETED